Biomaterial drug delivery and surface modification compositions

1. A medical device coating comprising an emulsion comprising:

an oil phase comprising a bioabsorbable terpolymer comprising from about 30 to about 50 weight percent of a polyoxyalkylene copolymer, from about 40 to about 50 weight percent epsilon-caprolactone, the balance of the copolymer comprising at least one other copolymerizable monomer selected from the group consisting of glycolide, lactide, p-dioxanone and trimethylene carbonate, in combination with a polymer comprising two or more monomers selected from the group consisting of lactide, glycolide, lactic-acid, lactones, glycolic acid, carbonates, orthoesters, absorbable urethanes, absorbable nylons, polyethylene glycol-polypropylene glycol, polystyrene, n-vinyl pyrrolidine, n-vinyl pyridine, C 1 -C 12 acrylate monomer, C 1 -C 12 methacrylate monomer, hydroxyethyl methacrylate, hydroxypropyl methacrylate, acrylic acid, potassium sulfopropyl acrylate, potassium sulfopropyl methacrylate, and 2-methacryloyl phosphorocholine, in combination with at least one organic solvent; and

an aqueous phase comprising at least one antimicrobial component selected from the group consisting of antimicrobial proteins, peptides, fragments thereof, and combinations thereof.

2. The coating of claim 1 , wherein the polymer comprises a lactide/glycolide copolymer.

3. The coating of claim 1 , wherein the at least one antimicrobial component is selected from the group consisting of lactoferrin, lactoferricin, defensins, cathelicidin, histatins, cecropins, magainin, and combinations thereof.

4. The coating of claim 1 wherein coating further comprises a vinyl pyrrolidone component selected from the group consisting of vinyl pyrrolidone homopolymers, vinyl pyrrolidone copolymers, and blends thereof optionally in combination with additional monomers or polymers.

5. The coating of claim 1 , wherein the coating further comprises one or more fatty acid components selected from the group consisting of fatty acids, fatty acid salts and salts of fatty acid esters.

6. The coating of claim 5 , wherein the fatty acid component comprises a salt of a fatty acid ester selected from the group consisting of calcium stearoyl lactylate, magnesium stearoyl lactylate, aluminum stearoyl lactylate, barium stearoyl lactylate, zinc stearoyl lactylate calcium palmityl lactylate, magnesium palmityl lactylate, aluminum palmityl lactylate, barium palmityl lactylate, or zinc palmityl lactylate, calcium olelyl lactylate, magnesium olelyl lactylate, aluminum olelyl lactylate, barium olelyl lactylate, and zinc olelyl lactylate.

7. The coating of claim 1 , wherein the medical device is selected from the group consisting staples, clips, drug delivery devices, stents, pins, screws, sutures, prosthetic ligaments, prosthetic tendons, woven mesh, tissue scaffolds, lyophilized and biologic mesh, composite mesh, gauze, dressings, and growth matrices.

8. The coating of claim 1 , wherein the organic solvent is selected from the group consisting of chloroform, dichloromethane, carbon tetrachloride, xylene, benzene, toluene, hexane, cyclohexane, diethyl ether, carbon disulfide, and combinations thereof.

9. The coating of claim 1 , wherein the ratio of the organic solution to the aqueous solution may be from about 1:1 to about 20:1.

10. A medical device coating comprising an emulsion comprising:

an oil phase comprising a bioabsorbable terpolymer comprising from about 30 to about 50 weight percent of a polyoxyalkylene copolymer, from about 40 to about 50 weight percent epsilon-caprolactone, the balance of the copolymer comprising at least one other copolymerizable monomer selected from the group consisting of glycolide, lactide, p-dioxanone and trimethylene carbonate, in combination with a polymer comprising two or more monomers selected from the group consisting of lactide, glycolide, lactic-acid, lactones, glycolic acid, carbonates, orthoesters, absorbable urethanes, absorbable nylons, polyethylene glycol-polypropylene glycol, polystyrene, n-vinyl pyrrolidine, n-vinyl pyridine, C 1 -C 12 acrylate monomer, C 1 -C 12 methacrylate monomer, hydroxyethyl methacrylate, hydroxypropyl methacrylate, acrylic acid, potassium sulfopropyl acrylate, potassium sulfopropyl methacrylate, and 2-methacryloyl phosphorocholine, in combination with at least one organic solvent;

at least one surfactant; and

an aqueous phase comprising at least one antimicrobial component selected from the group consisting of lactoferrin, lactoferricin, defensins, cathelicidin, histatins, cecropins, magainin, and combinations thereof.

11. The coating of claim 10 , wherein the polymer comprises a lactide/glycolide copolymer.

12. The coating of claim 10 , wherein the at least one surfactant is selected from the group consisting of alcohol ethoxylates, glycerol esters, polyoxyethylene esters, glycol esters of fatty acids, and combinations thereof.

13. The coating of claim 10 , wherein the coating further comprises a vinyl pyrrolidone component selected from the group consisting of vinyl pyrrolidone homopolymers, vinyl pyrrolidone copolymers, and blends thereof, optionally in combination with additional monomers or polymers.

14. The coating of claim 10 , wherein the coating further comprises one or more fatty acid components selected from the group consisting of fatty acids, fatty acid salts and salts of fatty acid esters.

15. The coating of claim 14 , wherein the fatty acid component comprises a salt of a fatty acid ester selected from the group consisting of calcium stearoyl lactylate, magnesium stearoyl lactylate, aluminum stearoyl lactylate, barium stearoyl lactylate, zinc stearoyl lactylate calcium palmityl lactylate, magnesium palmityl lactylate, aluminum palmityl lactylate, barium palmityl lactylate, or zinc palmityl lactylate, calcium olelyl lactylate, magnesium olelyl lactylate, aluminum olelyl lactylate, barium olelyl lactylate, and zinc olelyl lactylate.

16. The coating of claim 10 , wherein the medical device is selected from the group consisting staples, clips, drug delivery devices, stents, pins, screws, sutures, prosthetic ligaments, prosthetic tendons, woven mesh, tissue scaffolds, lyophilized and biologic mesh, composite mesh, gauze, dressings, and growth matrices.

17. The coating of claim 10 , wherein the organic solvent is selected from the group consisting of chloroform, dichloromethane, carbon tetrachloride, xylene, benzene, toluene, hexane, cyclohexane, diethyl ether, carbon disulfide, and combinations thereof.

18. The coating of claim 10 , wherein the ratio of the organic solution to the aqueous solution may be from about 1:1 to about 20:1.